HQY Form 4: EVP Delano Ladd disposes of 977 HQY shares
Rhea-AI Filing Summary
Insider sale recorded: An officer and director, Delano Ladd (EVP, General Counsel), reported selling 977 shares of HealthEquity, Inc. (HQY) on 10/06/2025 at a reported price of $88.5674 per share. After the transaction, the reporting person beneficially owned 78,479 shares directly. The filing is a standard Section 16 Form 4 that discloses a non-derivative sale and includes a manual signature dated 10/08/2025.
The record shows a straightforward disposition of common stock by a company insider with no derivative transactions disclosed. The form supplies clear numbers for the shares sold, sale price, and remaining beneficial ownership but does not state the reason for the sale or any planned future transactions.
Positive
- Timely disclosure of the insider sale via a completed Section 16 Form 4
- Clear numeric detail provided: 977 shares sold at $88.5674, leaving 78,479 shares
Negative
- Insider sold shares, reducing direct ownership by 977 shares on 10/06/2025
- No 10b5-1 plan box is indicated, so the filing does not show the sale was under a pre-arranged plan
Insights
TL;DR: An officer sold a small portion of holdings; disclosure is complete and routine.
The filing documents a direct sale of 977 common shares by an officer and director at $88.5674 on 10/06/2025, leaving 78,479 shares beneficially owned. This is a non-derivative transaction reported on a standard Section 16 Form 4, which fulfills required insider reporting obligations.
Such sales can be routine (liquidity, tax needs) or part of pre-arranged plans; no 10b5-1 plan box is checked on the form so no contract-based affirmative defense is indicated. Monitor subsequent filings for additional sales or disclosures within the next few months to confirm whether this is isolated or part of a larger pattern.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 977 | $88.5674 | $87K |